MARKET

PODD

PODD

Insulet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

236.34
+7.91
+3.46%
After Hours: 236.34 0 0.00% 17:03 05/18 EDT
OPEN
229.24
PREV CLOSE
228.43
HIGH
244.21
LOW
229.24
VOLUME
714.90K
TURNOVER
--
52 WEEK HIGH
306.46
52 WEEK LOW
164.40
MARKET CAP
15.66B
P/E (TTM)
1765.05
1D
5D
1M
3M
1Y
5Y
Great Point Partners Llc Buys Mirati Therapeutics Inc, Biogen Inc, Exelixis Inc, Sells GW ...
GuruFocus News · 4h ago
Tech focused, Lone Pine Capital acquires new position in Workday, exits Docusign, expands stake in Snowflake
Stephen Mandel’s Lone Pine Capital in its recent 13F filing indicated total portfolio value of $27.53B spread across 38 holdings.As per data indicated by Gurfocus.com, Lone Pine's nearly half of
Seekingalpha · 10h ago
Bridger Management, Llc Buys Sotera Health Co, Microsoft Corp, Insulet Corp, Sells American ...
GuruFocus News · 4d ago
Insider Trends: Insider Sale at Insulet Scaling Back 90-Days of Buying
MT Newswires · 4d ago
BRIEF-Insulet Says Entered Into Exchange Agreements With Certain Holders Of Outstanding 1.375% Convertible Senior Notes
reuters.com · 4d ago
Winslow Capital Management, LLC Buys Starbucks Corp, Hilton Worldwide Holdings Inc, Edwards ...
GuruFocus News · 5d ago
Asia Pacific Wearable Injectors Market SWOT Analysis 2021, Drivers, Trends, Growth, Key Indicators and Forecast to 2027 | Top Players F. Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed AG, Tandem Diabetes Care, Inc
May 12, 2021 (Heraldkeepers) -- Pre & Post Covid-19 Impact and Recovery Analysis (Estimates) is Covered in Wearable Injectors Market Research Report....
Heraldkeepers · 6d ago
Insulin Pump Market Size 2021 | Is Projected to Reach USD 11.86 Billion by 2028, Exhibiting a CAGR of 16.0%
Pune, India, May 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- Pune, India, May 12, 2021 (GLOBE NEWSWIRE) -- The global insulin pump market size is projected to...
GlobeNewswire · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PODD. Analyze the recent business situations of Insulet through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PODD stock price target is 282.06 with a high estimate of 323.00 and a low estimate of 250.00.
EPS
Institutional Holdings
Institutions: 594
Institutional Holdings: 76.80M
% Owned: 115.88%
Shares Outstanding: 66.27M
TypeInstitutionsShares
Increased
158
4.92M
New
43
704.06K
Decreased
162
3.50M
Sold Out
53
744.24K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.39%
Healthcare Equipment & Supplies
+0.35%
Key Executives
Chairman/Independent Director
Timothy Scannell
Chairman/Independent Director
timothy Scannell
President/Chief Executive Officer/Director
Shacey Petrovic
Chief Financial Officer/Executive Vice President/Treasurer
Wayde McMillan
Chief Operating Officer/Executive Vice President
Charles Alpuche
Executive Vice President
Bret Christensen
Senior Vice President/General Counsel/Secretary
John Kapples
Senior Vice President
Eric Benjamin
Senior Vice President
Michael Spears
Director
Wayne Frederick
Independent Director
Sally Crawford
Independent Director
James Hollingshead
Independent Director
Jessica Hopfield
Independent Director
David Lemoine
Independent Director
Michael Minogue
Independent Director
Corinne Nevinny
No Data
About PODD
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.

Webull offers kinds of Insulet Corporation stock information, including NASDAQ:PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.